Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease.

Alzheimer's disease (AD) is characterized by the misfolding and plaque-like accumulation of a naturally occurring peptide in the brain called amyloid beta (Abeta). Recently, this process has been associated with the binding of metal ions such as iron (Fe), copper (Cu), and zinc (Zn). It is thought that metal dyshomeostasis is involved in protein misfolding and may lead to oxidative stress and neuronal damage. However, the exact role of the misfolded proteins and metal ions in the degenerative process of AD is not yet clear. In this study, we used synchrotron Fourier transform infrared micro-spectroscopy (FTIRM) to image the in situ secondary structure of the amyloid plaques in brain tissue of AD patients. These results were spatially correlated with metal ion accumulation in the same tissue sample using synchrotron X-ray fluorescence (SXRF) microprobe. For both techniques, a spatial resolution of 5-10 microm was achieved. FTIRM results showed that the amyloid plaques have elevated beta-sheet content, as demonstrated by a strong amide I absorbance at 1625cm(-1). Using SXRF microprobe, we find that AD tissue also contains "hot spots" of accumulated metal ions, specifically Cu and Zn, with a strong spatial correlation between these two ions. The "hot spots" of accumulated Zn and Cu were co-localized with beta-amyloid plaques. Thus for the first time, a strong spatial correlation has been observed between elevated beta-sheet content in Abeta plaques and accumulated Cu and Zn ions, emphasizing an association of metal ions with amyloid formation in AD.

[1]  R. Ravid,et al.  Increased amount of zinc in the hippocampus and amygdala of Alzheimer's diseased brains A proton-induced X-ray emission spectroscopic analysis of cryostat sections from autopsy material , 1997, Journal of Neuroscience Methods.

[2]  M. Chance,et al.  In situ chemistry of osteoporosis revealed by synchrotron infrared microspectroscopy. , 2003, Bone.

[3]  K. Iwata,et al.  The Alzheimer's peptide a beta adopts a collapsed coil structure in water. , 2000, Journal of structural biology.

[4]  C. Yip,et al.  Amyloid-beta peptide assembly: a critical step in fibrillogenesis and membrane disruption. , 2001, Biophysical journal.

[5]  J. D. Robertson,et al.  Copper, iron and zinc in Alzheimer's disease senile plaques , 1998, Journal of the Neurological Sciences.

[6]  A. Donald,et al.  The binding of thioflavin-T to amyloid fibrils: localisation and implications. , 2005, Journal of structural biology.

[7]  L. S. Palmer.  THE PHYSIOLOGICAL RELATION OF PLANT CAROTINOIDS TO THE CAROTINOIDS OF THE COW, HORSE, SHEEP, GOAT, PIG, AND HEN , 1916 .

[8]  Kunio,et al.  The Role of β-Amyloid in the Development of Alzheimer’s Disease , 1995 .

[9]  R. Murphy,et al.  Solvent effects on self-assembly of beta-amyloid peptide. , 1995, Biophysical journal.

[10]  Xudong Huang,et al.  Redox‐Active Metals, Oxidative Stress, and Alzheimer's Disease Pathology , 2004, Annals of the New York Academy of Sciences.

[11]  C. Masters,et al.  Rapid induction of Alzheimer A beta amyloid formation by zinc. , 1994, Science.

[12]  D. Holtzman,et al.  In situ atomic force microscopy study of Alzheimer’s β-amyloid peptide on different substrates: New insights into mechanism of β-sheet formation , 1999 .

[13]  W. Halliday,et al.  In situ characterization of beta-amyloid in Alzheimer's diseased tissue by synchrotron Fourier transform infrared microspectroscopy. , 1996, Biophysical journal.

[14]  Xudong Huang,et al.  The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. , 1999, Biochemistry.

[15]  A. Odaka,et al.  Amyloid β protein 1–42/43 (Aβ 1–42/43) in cerebellar diffuse plaques: enzyme-linked immunosorbent assay and immunocytochemical study , 1995, Brain Research.

[16]  Moir,et al.  Mounting evidence for the involvement of zinc and copper in Alzheimer's disease , 1999, European journal of clinical investigation.

[17]  S. Sutton,et al.  Applications of Synchrotron Radiation in Low-Temperature Geochemistry and Environmental Science , 2002 .

[18]  H. Mantsch,et al.  Beware of proteins in DMSO. , 1991, Biochimica et biophysica acta.

[19]  R. Orlando,et al.  Trifluoroacetic acid pretreatment reproducibly disaggregates the amyloid β-peptide , 1997 .

[20]  T. Konno.  Amyloid-induced aggregation and precipitation of soluble proteins: an electrostatic contribution of the Alzheimer's beta(25-35) amyloid fibril. , 2001, Biochemistry.

[21]  I. Dixon,et al.  Fourier transform infrared evaluation of microscopic scarring in the cardiomyopathic heart: effect of chronic AT1 suppression. , 2003, Analytical biochemistry.

[22]  C. Masters,et al.  Alzheimer's Disease Amyloid-β Binds Copper and Zinc to Generate an Allosterically Ordered Membrane-penetrating Structure Containing Superoxide Dismutase-like Subunits* , 2001, The Journal of Biological Chemistry.

[23]  D. Hamerman,et al.  Alterations in mineral composition observed in osteoarthritic joints of cynomolgus monkeys. , 2004, Bone.

[24]  L. Miller,et al.  Development and applications of an epifluorescence module for synchrotron x-ray fluorescence microprobe imaging , 2005 .

[25]  Peter J. Eng,et al.  Microfluorescence and Microtomography Analyses of Heterogeneous Earth and Environmental Materials , 2002 .

[26]  Lisa M. Miller,et al.  Infrared imaging of compositional changes in inflammatory cardiomyopathy , 2005 .

[27]  J. Miklossy,et al.  Combining IR spectroscopy with fluorescence imaging in a single microscope: Biomedical applications using a synchrotron infrared source (invited) , 2002 .

[28]  A. Rich,et al.  Direct conversion of an oligopeptide from a β-sheet to an α-helix: A model for amyloid formation , 1997, The Excitement of Discovery: Selected Papers of Alexander Rich.

[29]  Math P. Cuajungco,et al.  Zinc takes the center stage: its paradoxical role in Alzheimer’s disease , 2003, Brain Research Reviews.

[30]  H. Susi,et al.  Estimation of beta-structure content of proteins by means of deconvolved FTIR spectra. , 1985, Journal of biochemical and biophysical methods.

[31]  C. Barrow,et al.  Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra. , 1992, Journal of molecular biology.

[32]  C. Barrow,et al.  Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition. , 1991, Science.

[33]  Bart Kahr,et al.  Imaging linear birefringence and dichroism in cerebral amyloid pathologies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Ashley I. Bush,et al.  The metallobiology of Alzheimer's disease , 2003, Trends in Neurosciences.

[35]  Peter Lasch,et al.  In situ identification of protein structural changes in prion-infected tissue. , 2003, Biochimica et biophysica acta.

[36]  Xudong Huang,et al.  Evidence that the β-Amyloid Plaques of Alzheimer's Disease Represent the Redox-silencing and Entombment of Aβ by Zinc* , 2000, The Journal of Biological Chemistry.

[37]  R Mendelsohn,et al.  Spectroscopic Characterization of Collagen Cross‐Links in Bone , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[38]  P. R. Hof,et al.  An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease , 1992, Experientia.

[39]  L. Serpell,et al.  The protofilament substructure of amyloid fibrils. , 2000, Journal of molecular biology.

[40]  H. Takeuchi,et al.  Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes. , 2000, Biochemistry.

[41]  H. Susi,et al.  Examination of the secondary structure of proteins by deconvolved FTIR spectra , 1986, Biopolymers.